Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis

MLA

Xinhui Hu, et al. “Fibroblast Growth Factor 21 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Patients Undergoing Maintenance Hemodialysis.” Renal Failure, vol. 46, no. 1, Dec. 2024. EBSCOhost, https://doi.org/10.1080/0886022X.2024.2302407.

APA

Xinhui Hu, Hong Ding, Qing Wei, Ruoxin Chen, Weiting Zhao, Liqiong Jiang, Jing Wang, Haifei Liu, Jingyuan Cao, Hong Liu, & Bin Wang. (2024). Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis. Renal Failure, 46(1). https://doi.org/10.1080/0886022X.2024.2302407

Chicago

Xinhui Hu, Hong Ding, Qing Wei, Ruoxin Chen, Weiting Zhao, Liqiong Jiang, Jing Wang, et al. 2024. “Fibroblast Growth Factor 21 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Patients Undergoing Maintenance Hemodialysis.” Renal Failure 46 (1). doi:10.1080/0886022X.2024.2302407.